NeuMoDx Cartridge-For in vitro diagnostic use with NeuMoOx Molecular Systems with either of the...

FDA Device Recall #Z-1000-2022 — Class II — February 18, 2022

Recall Summary

Recall Number Z-1000-2022
Classification Class II — Moderate risk
Date Initiated February 18, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm NeuMoDx Molecular Inc
Location Ann Arbor, MI
Product Type Devices
Quantity 773 (72 US and 701 ROW) cases (48 cartridges/case)

Product Description

NeuMoDx Cartridge-For in vitro diagnostic use with NeuMoOx Molecular Systems with either of the following assays: NeuMoDx SARS CoV-2 Test Strip (REF 300800) NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip (REF 300900) NeuMoDx Laboratory Developed Tests (LDTs) for SARS-CoV-2 RNA detection Note: Results for targets other than SARS-CoV-2 are not impacted by this Urgent Medical Device Correction Ref. Number: 100100

Reason for Recall

Potential for false positive results for SARS-CoV-2 in identified lots of cartridges, when used in conjunction with assays containing SARS-CoV-2 targets (NeuMoDx" SARS-CoV-2 Test Strip Cat #300800 and NeuMoDx" Flu A-B/RSV/SARS-CoV-2 Vantage Assay Cat #300900) result incorrect management of patients

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of OH, MO, VA, MI, MI, FL, MD, IA, NY, MO and the countries of Italy, Germany, Switzerland, Sweden, Netherlands, Finland, Spain, United Kingdom, Belgium, Austria, Hong Kong, France, Denmark, Slovenia.

Lot / Code Information

Lot Numbers: 115424, 115425, 115426, 115427, 115429, 115431. GTIN: 10814278020274

Other Recalls from NeuMoDx Molecular Inc

Recall # Classification Product Date
Z-2255-2023 Class II NeuMoDx Cartridge-used for extraction, purifica... May 24, 2023
Z-2093-2023 Class III NeuMoDx SARS-CoV-2 Assay -IVD intended for the... May 15, 2023
Z-1251-2022 Class II NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Str... May 13, 2022
Z-0738-2022 Class II NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Str... Jan 21, 2022
Z-1978-2021 Class II NeuMoDx Cartridge, For In Vitro Diagnostic Use ... May 4, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.